https://www.selleckchem.com/products/adt-007.html
Irregular sleep-wake rhythm disorder (ISWRD) is a common sleep disorder in individuals with Alzheimer's disease dementia (AD-D). This exploratory phase 2 proof-of-concept and dose-finding clinical trial evaluated the effects of lemborexant compared with placebo on circadian rhythm parameters, nighttime sleep, daytime wakefulness and other clinical measures of ISWRD in individuals with ISWRD and mild to moderate AD-D. Multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Sites in the United States, Japan and th
Like
Comment
Share
